Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

Key Ratios

Key Ratios

Price & Volume

Recent Price $14.00
52 Week High $14.60
52 Week Low $5.50
Volume (10 Day Average) (Mil) $0.26
Beta $-0.06

Dividends

Yield (%) --
Ex-Dividend Date
Dividend Rate --%

Financial Strength

Quick Ratio (MRQ) --
Current Ratio (MRQ) $4.57
LT Debt to Equity (MRQ) (%) --
Total Debt to Equity (MRQ) (%) --

Valuation

P/E (TTM) --
Price to Revenue (TTM) $295.61
Price to Cash Flow (TTM) --
Price to Book (MRQ) $5.34

Per Share

Revenue/Share (TTM) $0.06
EPS Fully Diluted (MRQ) $-0.68
Book Value/Share (MRQ) $2.62
Cash Flow/Share (TTM) $-2.59
Cash (MRQ) $2.59

Management Effectiveness

Return on Equity (TTM) (%) -84.95
Return on Assets (TTM) (%) -71.95
Return on Investment (TTM) (%) -84.77

Profitability

Operating Margin (TTM) (%) -4,738.38
Net Profit Margin (TTM) (%) -4,683.38
Gross Margin (TTM) (%) --


Copyright 2017 - Stemline Therapeutics, Inc. All rights reserved